Ilan Ziv
Research Subjects
Research Interests
Ilan Ziv has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Anat Shirvan
NeuroSurvival Technologies (NST) Ltd
2 shared publicationsAyelet Reshef
NeuroSurvival Technologies (NST) Ltd
2 shared publicationsAhuva Shina
Mt. Scopus and the Hebrew University Medical School
1 shared publicationAlfonso Bentolila
NeuroSurvival Technologies (NST) Ltd
1 shared publicationAnat Achiron
Department of Neurology, Beilinson Medical Center, and the Felsenstein Research Institute, Petah Tiqva, Israel
1 shared publication- Anat Shirvan
NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel
1 shared publication
Latest Publications
- 8 October 2011
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 38 (12) , 2287
Erratum to: ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis
- 8 October 2011
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 38 (12) , 2287
Erratum to: ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis
- 7 September 2010
- Published by Springer Nature in Apoptosis
- Vol. 15 (11) , 1285-1291
Editorial: apoptosis in the aging brain
- 7 September 2010
- Published by Springer Nature in Apoptosis
- Vol. 15 (11) , 1285-1291
Editorial: apoptosis in the aging brain
- Open Access
- 19 May 2010
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 51 (6) , 837-840
Small-Molecule Biomarkers for Clinical PET Imaging of Apoptosis
Apoptosis is a fundamental biologic process. Molecular imaging of apoptosis in vivo may have important implications for clinical practice, assisting in early detection of disease, monitoring of disease course, assessment of treatment efficacy, or development of new therapies. Although a PET probe for clinical imaging of apoptosis would be highly desirable, this is yet an unachieved goal, mainly because of the required challenging integration of various features, including sensitive and selective detection of the apoptotic cells, clinical aspects such as favorable biodistribution and safety profiles, and compatibility with the radiochemistry and imaging routines of clinical PET centers. Several approaches are being developed to address this challenge, all based on novel small-molecule structures targeting various steps of the apoptotic cascade. This novel concept of small-molecule PET probes for apoptosis is the focus of this review.
- 19 May 2010
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 51 (6) , 837-840
Open AccessSmall-Molecule Biomarkers for Clinical PET Imaging of Apoptosis
Apoptosis is a fundamental biologic process. Molecular imaging of apoptosis in vivo may have important implications for clinical practice, assisting in early detection of disease, monitoring of disease course, assessment of treatment efficacy, or development of new therapies. Although a PET probe for clinical imaging of apoptosis would be highly desirable, this is yet an unachieved goal, mainly because of the required challenging integration of various features, including sensitive and selective detection of the apoptotic cells, clinical aspects such as favorable biodistribution and safety profiles, and compatibility with the radiochemistry and imaging routines of clinical PET centers. Several approaches are being developed to address this challenge, all based on novel small-molecule structures targeting various steps of the apoptotic cascade. This novel concept of small-molecule PET probes for apoptosis is the focus of this review.
- 1 January 1994
- Published by Wiley in Movement Disorders
- Vol. 9 (5) , 582-583
First emergence of ?delayed-on? and ?dose failure? phenomena in a patient with Parkinson's disease following vagotomy
- 1 January 1994
- Published by Wiley in Movement Disorders
- Vol. 9 (5) , 582-583
First emergence of ?delayed-on? and ?dose failure? phenomena in a patient with Parkinson's disease following vagotomy